title: Randomized clinical trials in gastrointestinal stromal tumors.
abstract: Gastrointestinal (GI) stromal tumor (GIST) is the most common mesenchymal tumor of the GI tract, constituting 80% of all GI mesenchymal tumors and approximately 20% of all small bowel malignancies, excluding lymphomas. This article provides a summary of recent randomized clinical trials of these tumors.
authors.affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 203, New York, NY 10065, USA.
authors.forename: Peter A
authors.initials: PA
authors.lastname: Learn
authors.forename: Jason K
authors.initials: JK
authors.lastname: Sicklick
authors.forename: Ronald P
authors.initials: RP
authors.lastname: DeMatteo
mesh_terms: D046152:Gastrointestinal Stromal Tumors / Q000628:therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic